Javascript must be enabled to continue!
<b>Multitarget-Directed Multiple Ligands in Anti-VEGF Resistant Glioblastoma Therapeutics: An in Silico Approach to Identify Potential Phytochemicals</b>
View through CrossRef
Angiogenesis is an important process in tumor progression. Vascular endothelial growth factor (VEGF) is the key factor regulating angiogenesis, and hence, anti-VEGF therapy is considered a useful therapeutic approach in tumor conditions. However, the drug resistance and lack of efficacy of existing drugs limit the potential of such a therapeutic approach in certain cases, and the tumor growth will continue through alternative mechanisms. Glioblastoma (GBM) is one such type of tumor that shows resistance to anti-VEGF therapy. Previously, we identified the hub genes differentially expressed in anti-VEGF resistance in GBM. Medhya Rasayana, an Ayurvedic formulation, is used for the management of neurological disorders. In the present study, we used computational docking methods to identify the phytochemicals present in the medicinal plants of Medhya Rasayana, which can target the proteins expressed by the hub genes associated with anti-VEGF resistance. Network pharmacological analysis was also performed to identify the highly effective phytochemicals for a possible adjuvant therapy. Results showed that multiple phytochemicals of Glycirrhiza glabra Linn, Evolvulus alsinoides, and Celastrus paniculatus target the anti-VGEF resistant proteins in GBM. This indicates the multi-targeting property of phytocompounds of Medhya Rasayana plants, which may be considered for adjuvant therapy along with anti-VEGF therapy.
Received: 10 July 2024 | Revised: 11 October 2024 | Accepted: 6 January 2025
Conflicts of Interest
The authors declare that they have no conflicts of interest to this work.
Data Availability Statement
The data that support this work are available upon reasonable request to the corresponding author.
Author Contribution Statement
Kesavan R. Arya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing, Visualization, Funding acquisition. Sasikumar J. Soumya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing,Visualization, Funding acquisition. Anuroopa G. Nadh: Formal analysis, Investigation, Funding acquisition. Thankamani R. Aswathy: Formal analysis, Investigation. Vijayalakshmi B.: Investigation. Achuthsankar S. Nair: Resources, Project administration. Oommen V. Oommen: Validation, Resources, Writing - review & editing, Project administration. Perumana R. Sudhakaran: Conceptualization, Methodology, Validation, Investigation, Resources, Writing - review & editing, Project administration, Funding acquisition.
Title: <b>Multitarget-Directed Multiple Ligands in Anti-VEGF Resistant Glioblastoma Therapeutics: An in Silico Approach to Identify Potential Phytochemicals</b>
Description:
Angiogenesis is an important process in tumor progression.
Vascular endothelial growth factor (VEGF) is the key factor regulating angiogenesis, and hence, anti-VEGF therapy is considered a useful therapeutic approach in tumor conditions.
However, the drug resistance and lack of efficacy of existing drugs limit the potential of such a therapeutic approach in certain cases, and the tumor growth will continue through alternative mechanisms.
Glioblastoma (GBM) is one such type of tumor that shows resistance to anti-VEGF therapy.
Previously, we identified the hub genes differentially expressed in anti-VEGF resistance in GBM.
Medhya Rasayana, an Ayurvedic formulation, is used for the management of neurological disorders.
In the present study, we used computational docking methods to identify the phytochemicals present in the medicinal plants of Medhya Rasayana, which can target the proteins expressed by the hub genes associated with anti-VEGF resistance.
Network pharmacological analysis was also performed to identify the highly effective phytochemicals for a possible adjuvant therapy.
Results showed that multiple phytochemicals of Glycirrhiza glabra Linn, Evolvulus alsinoides, and Celastrus paniculatus target the anti-VGEF resistant proteins in GBM.
This indicates the multi-targeting property of phytocompounds of Medhya Rasayana plants, which may be considered for adjuvant therapy along with anti-VEGF therapy.
Received: 10 July 2024 | Revised: 11 October 2024 | Accepted: 6 January 2025
Conflicts of Interest
The authors declare that they have no conflicts of interest to this work.
Data Availability Statement
The data that support this work are available upon reasonable request to the corresponding author.
Author Contribution Statement
Kesavan R.
Arya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing, Visualization, Funding acquisition.
Sasikumar J.
Soumya: Methodology, Formal analysis, Investigation, Writing - original draft, Writing - review & editing,Visualization, Funding acquisition.
Anuroopa G.
Nadh: Formal analysis, Investigation, Funding acquisition.
Thankamani R.
Aswathy: Formal analysis, Investigation.
Vijayalakshmi B.
: Investigation.
Achuthsankar S.
Nair: Resources, Project administration.
Oommen V.
Oommen: Validation, Resources, Writing - review & editing, Project administration.
Perumana R.
Sudhakaran: Conceptualization, Methodology, Validation, Investigation, Resources, Writing - review & editing, Project administration, Funding acquisition.
Related Results
Investigating the role of the apelinergic system in glioblastoma
Investigating the role of the apelinergic system in glioblastoma
<p>Elucidating the molecular signalling circuitry that underpins the pathogenesis of cancers is critical to understanding and developing effective treatment paradigms for can...
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma*
Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma*
Background & Aims: Vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 and VEGF-R2) are the most important angiogenesis stimulating factors in pancreatic cance...
The correlation of MMP-9 and VEGF expressions towards nasopharyngeal angiofibroma clinical stage
The correlation of MMP-9 and VEGF expressions towards nasopharyngeal angiofibroma clinical stage
ABSTRACTBackground: Nasopharyngeal angiofibroma (NA) is a benign tumor with a destructive tendency, commonly affecting male adolescents. The management of NA could become quite a c...
VEGF Receptor Signal Transduction
VEGF Receptor Signal Transduction
The family of vascular endothelial growth factors (VEGFs) currently includes VEGF-A, -B, -C, -D, -E, and placenta growth factor (PlGF). Several of these factors, notably VEGF-A, ex...
ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN PATHOGENESIS OF KNEE OSTEOARTHRITIS
ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN PATHOGENESIS OF KNEE OSTEOARTHRITIS
Recent evidences suggest that angiogenesis and inflammation contribute to the development and progression of knee osteoarthritis (OA). Vascular endothelial growth factor (VEGF) is ...
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas
C. Christov, H. Adle‐Biassette, C. Le Guerinel, S. Natchev and R. K. Gherardi (1998) Neuropathology and Applied Neurobiology24, 29–35Immunohistochemical detection of vascular endot...
Abstract 5427: Inducing tumor apoptosis by redirecting VEGF to activate cell death receptors
Abstract 5427: Inducing tumor apoptosis by redirecting VEGF to activate cell death receptors
Abstract
Vascular endothelial growth factor (VEGF) is a key tumor angiogenesis factor that is overexpressed by many tumors; the Fas/CD95 death receptor induces apopt...
Abstract 1580: Molecular mechanisms of OSM-induced VEGF in breast cancer
Abstract 1580: Molecular mechanisms of OSM-induced VEGF in breast cancer
Abstract
Oncostatin M (OSM) is an interleukin-6 (IL-6) family cytokine that has been shown to induce expression of vascular endothelial growth factor (VEGF) in astro...

